Victrex plc (LON:VCT) has earned an average rating of “Hold” from the twelve ratings firms that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and three have issued a buy recommendation on the company. The average 12-month price target among brokerages that have covered the stock in the last year is GBX 2,114.36 ($28.05).
VCT has been the topic of several research analyst reports. Liberum Capital reiterated a “buy” rating and issued a GBX 2,240 ($29.71) price objective on shares of Victrex plc in a report on Monday, September 4th. Credit Suisse Group reissued an “outperform” rating on shares of Victrex plc in a report on Friday, July 21st. Peel Hunt restated an “add” rating and issued a GBX 2,100 ($27.86) target price on shares of Victrex plc in a research report on Tuesday, July 25th. Deutsche Bank AG restated a “hold” rating and issued a GBX 1,850 ($24.54) target price on shares of Victrex plc in a research report on Friday, June 30th. Finally, J P Morgan Chase & Co lifted their price target on Victrex plc from GBX 1,800 ($23.88) to GBX 2,150 ($28.52) and gave the stock a “neutral” rating in a research note on Tuesday, September 5th.
Victrex plc (LON:VCT) traded up 2.29% on Friday, hitting GBX 2455.00. The stock had a trading volume of 198,614 shares. Victrex plc has a 12 month low of GBX 1,616.34 and a 12 month high of GBX 2,455.00. The company has a 50-day moving average of GBX 2,215.70 and a 200 day moving average of GBX 2,005.88. The company’s market cap is GBX 2.10 billion.
COPYRIGHT VIOLATION NOTICE: “Brokerages Set Victrex plc (VCT) Target Price at $2,114.36” was reported by BBNS and is owned by of BBNS. If you are viewing this piece of content on another publication, it was stolen and republished in violation of international trademark & copyright legislation. The legal version of this piece of content can be read at https://baseballnewssource.com/markets/brokerages-set-victrex-plc-vct-target-price-at-2114-36/1683068.html.
Victrex plc Company Profile
Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company’s operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets.
Receive News & Ratings for Victrex plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex plc and related companies with our FREE daily email newsletter.